Night-Sense
Noninvasive Sleep Hypoglycemia Alert System
Company Overview
Snapshot
Founded in May 2012 by Yoav Kan-tor and Shy Hefetz, Night-Sense operates with 1–10 employees. The company has raised $200,000 across one funding round. Night-Sense is currently in the Pre-Funding stage, developing a noninvasive wearable medical device.
Business overview
Night-Sense is a Health Tech & Life Sciences company focused on developing a noninvasive wearable medical device, Hypo-Sense, designed to provide real-time alerts for nocturnal hypoglycemia in insulin-dependent diabetics. The device utilizes a set of sensors and a personalized algorithm to continuously monitor patients during the night, alerting them or their caregivers to dangerous hypoglycemia events. The company operates within the Digital Healthcare and Medical Devices sectors, serving patients and healthcare providers in markets including Eastern Europe, Europe, China, Germany, India, and Japan.
Strategic signal
In November 2013, Night-Sense garnered significant media attention from publications like Globes and Algemeiner for its innovative Hypo-Sense device, which aims to protect diabetics from hypoglycemia during sleep. This early recognition highlighted the potential impact of its noninvasive wearable technology in addressing a critical need for diabetes management and signaled strong market interest in its medical device solution.
Log in to access full profile ›Company Intelligence Q&A
- What is Night-Sense's primary product?
- Night-Sense is developing Hypo-Sense, a noninvasive wearable medical device that provides real-time alerts for nocturnal hypoglycemia in diabetics who use insulin.
- When was Night-Sense founded?
- Night-Sense was founded in May 2012.
- Who are the co-founders of Night-Sense?
- Night-Sense was co-founded by Yoav Kan-tor and Shy Hefetz.
- What is the total disclosed funding raised by Night-Sense?
- Night-Sense has raised a total of $200,000 across one funding round. This includes an undisclosed grant from Tnufa: Matriculation, Doing Research.
- In what stage is Night-Sense currently operating?
- Night-Sense is currently in the Pre-Funding stage and its product is in the Clinical Trial stage.